India primed for biostatic outsourcing boom; CMO Aenove sold for $782M;

> India's market for the outsourcing of biostatic research is set to boom thanks to competitive pricing and burgeoning infrastructure, according to Beroe. News

> Bridgeport sold Munich-based CMO Aenove Group to BC Partners for a reported $782 million. The company operates in 5 countries across Europe and North America and has about 1,600 employees. Article

> The EMA is seeking CRO and sponsor input on a proposal to publicize more raw clinical trial data. The agency is looking to support independent research and public health without breaching patient confidentiality. Item

> India's custom research and manufacturing industry is also predicted to explode, with analysts forecasting 41.4% growth--more than three times the rate in the rest of the world. More

> German CRO Verum.de is targeting the U.S. market with the opening of a new facility in Carlsbad, CA. Release

> Almac says demand for its biologics work is on the rise, and the company is doubling its refrigeration capacity to accommodate the growth. Report

> Cato Research has signed a deal with Israel's Pluristem Therapeutics to conduct Phase II trials for a intermittent claudication treatment. News

Free Webinar

From Patient Adherence to Manufacturing Ease - Why Softgels Make Sense for Rx

Join Thermo Fisher Scientific’s upcoming webinar to learn why softgels offer numerous benefits for Rx drug development, including enhanced bioavailability, patient compliance and easy scale-up. Register Today.

Suggested Articles

Galapagos is selling off its contract research organization Fidelta for $37 million to Polish life science company Selvita.

Decentralized study company Medable has raised a large $91 million funding round as it continues to ramp up the deals in 2020.

Biotech IPOs are up over 40% year-to-date, but today’s markets have rewritten the rules for going public. Find out the new best practices for IPOs.